We are live on ! Find out more
OCGN icon

Ocugen

114 hedge funds and large institutions have $117M invested in Ocugen in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more call options, than puts

Call options by funds: $2.5M | Put options by funds: $1.2M

38% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 29

3.11% more ownership

Funds ownership: 38.02%41.14% (+3.1%)

11% less funds holding

Funds holding: 128114 (-14)

20% less capital invested

Capital invested by funds: $147M → $117M (-$29.5M)

43% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 30

Holders
114
Holders Change
-14
Holders Change %
-10.94%
% of All Funds
1.83%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
40
Reduced
29
Closed
30
Calls
$2.5M
Puts
$1.2M
Net Calls
+$1.31M
Net Calls Change
-$6K
Name Holding Trade Value Shares
Change
Change in
Stake
State Street
1
State Street
Massachusetts
$39.2M +$6.41M +4,113,822 +16%
BlackRock
2
BlackRock
New York
$19.6M +$2.35M +1,509,653 +11%
Vanguard Group
3
Vanguard Group
Pennsylvania
$15.4M +$246K +157,591 +1%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$5.39M +$526K +337,579 +9%
JP Morgan Chase
5
JP Morgan Chase
New York
$4.9M +$989K +634,682 +20%
Bank of America
6
Bank of America
North Carolina
$3.74M +$1.45M +933,507 +48%
Rafferty Asset Management
7
Rafferty Asset Management
New York
$3.21M +$837K +537,263 +28%
Northern Trust
8
Northern Trust
Illinois
$2.44M -$193K -123,907 -6%
Charles Schwab
9
Charles Schwab
California
$2.11M +$96.4K +61,826 +4%
UBS Group
10
UBS Group
Switzerland
$2.04M +$2M +1,283,489 +445%
Goldman Sachs
11
Goldman Sachs
New York
$2.01M -$699K -448,705 -23%
Renaissance Technologies
12
Renaissance Technologies
New York
$1.85M +$2.22M +1,422,856 New
Barclays
13
Barclays
United Kingdom
$1.67M +$132K +84,646 +7%
N
14
Nuveen
North Carolina
$1.5M +$716K +459,386 +66%
Citigroup
15
Citigroup
New York
$1.49M -$1.02M -654,557 -36%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$1.26M +$12.2K +7,806 +0.8%
Swiss National Bank
17
Swiss National Bank
Switzerland
$680K +$23.8K +15,300 +3%
Morgan Stanley
18
Morgan Stanley
New York
$581K +$36.5K +23,413 +6%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$570K -$1.21M -773,578 -64%
Two Sigma Investments
20
Two Sigma Investments
New York
$540K +$433K +278,131 +203%
SC
21
Sculptor Capital
New York
$408K
AllianceBernstein
22
AllianceBernstein
Tennessee
$386K +$162K +103,700 +54%
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$361K +$14.9K +9,578 +4%
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$357K +$7.25K +4,650 +2%
Citadel Advisors
25
Citadel Advisors
Florida
$340K +$35.2K +22,561 +9%

OCGN Hedge Fund Activity: Q4 2022 in Review

114 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Ocugen (OCGN) for Q4 2022, worth a combined $117M — down 20% from $147M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of OCGN and 17 opened new positions — a net loss of 13 holders — while 29 trimmed existing stakes and 40 added.

The largest buyer was State Street, adding an estimated $6.41M. The largest seller was Susquehanna International Group, cutting an estimated $1.21M.

  • 114 institutional investors held Ocugen (OCGN) as of Q4 2022, down from 128 in Q3 2022.
  • Funds reported $117M of Ocugen stock for Q4 2022, down 20% quarter-over-quarter.
  • 17 funds opened new Ocugen positions in Q4 2022 and 30 closed out, a net change of -13 holders.
  • The largest Ocugen buyer in Q4 2022 was State Street, an estimated $6.41M added.
  • The largest Ocugen seller in Q4 2022 was Susquehanna International Group, an estimated $1.21M sold.

Based on aggregated 13F filings for Q4 2022.